Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam B Weiner

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Current Opinion in Urology|July 8, 2025
What's in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer mattersAnael S Rizzo, Pratik Kanabur, Adam B Weiner
European Urology Oncology|June 16, 2019
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort StudyAdam B Weiner, Anuj S Desai, Joshua J Meeks
JAMA|March 21, 2018
Robotic-Assisted vs Laparoscopic Radical NephrectomyAdam B Weiner, Richard S Matulewicz, Joshua J Meeks
Cancer|September 15, 2016
Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer DatabaseAdam B Weiner, Shane M Pearce, Scott E Eggener
Case Reports in Urology|August 21, 2015
Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist DeviceJoseph J Pariser, Adam B Weiner, Gary D Steinberg
European Urology|September 19, 2018
"Real-world" Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate CancerAdam B Weiner, Edward M Schaeffer, Scott E Eggener
JAMA|December 7, 2017
Active Surveillance for Prostate CancerRichard S Matulewicz, Adam B Weiner, Edward M Schaeffer
The Journal of Urology|December 29, 2015
National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management DecisionsAdam B Weiner, Rena M Conti, Scott E Eggener
Current Treatment Options in Oncology|July 10, 2019
Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment ParadigmAdam B Weiner, Oluwarotimi S Nettey, Alicia K Morgans
Urologic Oncology|January 28, 2015
Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United StatesAdam B Weiner, Sanjay G Patel, Scott E Eggener
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Current Opinion in Urology|July 8, 2025
What's in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer mattersAnael S Rizzo, Pratik Kanabur, Adam B Weiner
European Urology Oncology|June 16, 2019
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort StudyAdam B Weiner, Anuj S Desai, Joshua J Meeks
JAMA|March 21, 2018
Robotic-Assisted vs Laparoscopic Radical NephrectomyAdam B Weiner, Richard S Matulewicz, Joshua J Meeks
Cancer|September 15, 2016
Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer DatabaseAdam B Weiner, Shane M Pearce, Scott E Eggener
Case Reports in Urology|August 21, 2015
Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist DeviceJoseph J Pariser, Adam B Weiner, Gary D Steinberg
European Urology|September 19, 2018
"Real-world" Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate CancerAdam B Weiner, Edward M Schaeffer, Scott E Eggener
JAMA|December 7, 2017
Active Surveillance for Prostate CancerRichard S Matulewicz, Adam B Weiner, Edward M Schaeffer
The Journal of Urology|December 29, 2015
National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management DecisionsAdam B Weiner, Rena M Conti, Scott E Eggener
Current Treatment Options in Oncology|July 10, 2019
Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment ParadigmAdam B Weiner, Oluwarotimi S Nettey, Alicia K Morgans
Urologic Oncology|January 28, 2015
Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United StatesAdam B Weiner, Sanjay G Patel, Scott E Eggener
Pageof 8